Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

NCT07527819 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer (TNBC)

Sponsor

Peter MacCallum Cancer Centre, Australia

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]